Newswise COVID Experts

Filters close

Showing results

2130 of 8416
2-Dec-2022 5:50 PM EST
Vaccine hesitancy predicts future COVID-19 vaccine side effects
Bar-Ilan University

The precise relationship between vaccine hesitancy and COVID-19 vaccination side effects has not previously been explored in vaccinated persons. A fundamental question arises in regard to the directionality of this vaccine hesitancy-vaccine side effect link, namely which variable predicts which. One possibility is that side effects from an earlier dose predict one’s vaccine hesitancy towards a later dose. Alternatively, one’s psychological negativity (hesitancy) towards an earlier dose could predict subsequent side effects from a later vaccination dose. The latter direction reflects a Nocebo effect, i.e., side effects driven by psychological factors rather than by an active treatment component. Results showed only the latter direction to be true. Namely, only earlier vaccine hesitancy towards the second COVID-19 dose predicted subsequent nocebo side-effects following the booster vaccination. To put this in perspective up to 16% of one’s vaccine side effects were explained by earlier va

2-Dec-2022 8:05 AM EST
Symptoms of long Covid in children may change over time
University College London

New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.

Released: 2-Dec-2022 4:45 PM EST
Fred Hutch at ASH: Global insights on AML outcomes, COVID-19 and cancer, CD19 CAR T-cell therapy updates, latest on precision oncology — and more
Fred Hutchinson Cancer Center

SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.

Newswise: Where did Omicron come from?
Released: 2-Dec-2022 10:50 AM EST
Where did Omicron come from?
Charité - Universitätsmedizin Berlin

First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.

Not for public release

Embargo will expire: 2-Dec-2022 12:15 AM EST Released to reporters: 29-Nov-2022 4:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2022 12:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

29-Nov-2022 7:55 PM EST
Long COVID patients and those with other illnesses experience similar, negative lingering effects during the pandemic
University of California, Los Angeles (UCLA), Health Sciences

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.

Released: 1-Dec-2022 10:05 AM EST
Bruma mental después de la covid: experto de Mayo Clinic describe los signos frecuentes
Mayo Clinic

uando comenzó la pandemia de COVID-19, los pacientes con síndrome de covid prolongada, también conocido como síndrome poscovid, informaron que tenían problemas con el pensamiento. A esto, se ha llegado a conocer como bruma mental y, aunque no sea el término médico oficial, la expresión es ahora una parte permanente de la discusión sobre la covid prolongada. En esta advertencia de un experto, el Dr. Greg Vanichkachorn, director del Programa para rehabilitación de la actividad después de la covid en Mayo Clinic, describe los problemas frecuentes de los pacientes.

Released: 1-Dec-2022 9:00 AM EST
Confusão mental pós-COVID: especialista da Mayo Clinic descreve os sintomas comuns
Mayo Clinic

Nos primeiros dias da pandemia de COVID-19, pacientes com a síndrome da COVID longa (também conhecida como síndrome pós-COVID), relataram problemas de raciocínio. Isso ficou conhecido como confusão ou névoa mental e, embora não seja um termo médico oficial, tornou-se parte permanente da discussão sobre a COVID longa. Neste alerta do especialista, o Dr. Greg Vanichkachorn, M.D., diretor do Programa de Reabilitação de Atividades da COVID da Mayo Clinic, descreve os problemas comuns vivenciados pelos pacientes.


Showing results

2130 of 8416

close
2.00636